Concepedia

Dennis Lovett

DL

Statistics

Publications

3

Citations

391

H-Index

3

Active since

1991

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dennis Lovett is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, bone marrow dosimetry, and acute myeloid leukemia treatment.

Publications per year

1991–2012

3

Publications

3

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.

David A. Scheinberg, Dennis Lovett, Chaitanya Divgi et al. · Journal of Clinical Oncology · 1991 · 227 citations

, , +17

Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.

Michael Schwartz, Dennis Lovett, Arlene Redner et al. · Journal of Clinical Oncology · 1993 · 131 citations

, , +15

Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates

Diego A. Gianolio, Cécile Rouleau, William E. Bauta et al. · Cancer Chemotherapy and Pharmacology · 2012 · 33 citations

, , +16

1–3 of 3